These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 4011667)

  • 1. [The pharmacokinetics of rifampicin in the intermittent treatment of patients with pulmonary tuberculosis. 2. The effect of rifampicin on the course of therapy for mycobacteriosis and non-tubercular infectious diseases].
    Eule H; Werner E; Winsel K; Iwainsky H
    Pharmazie; 1985 Apr; 40(4):276-7. PubMed ID: 4011667
    [No Abstract]   [Full Text] [Related]  

  • 2. Rifampicin: a review.
    Drugs; 1971; 1(5):354-98. PubMed ID: 4949280
    [No Abstract]   [Full Text] [Related]  

  • 3. On the pharmacokinetics of rifampicin I: Influence of dosage and duration of treatment with intermittent administration.
    Iwainsky H; Winsel K; Werner E; Eule H
    Scand J Respir Dis; 1974; 55(4):229-36. PubMed ID: 4438983
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial: Rifampicin.
    Med J Aust; 1973 Nov; 2(19):876. PubMed ID: 4765871
    [No Abstract]   [Full Text] [Related]  

  • 5. On the pharmacokinetics of rifampicin during treatment with intermittent administration. II. Influence of age and sex and of the patients.
    Iwainsky H; Winsel K; Werner E; Eule H
    Scand J Respir Dis; 1976; 57(1):5-11. PubMed ID: 1273544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic effect of rifampicin on re-treatment cases of pulmonary tuberculosis. The second study: a study on the combined therapy of rifampicin with ethambutol and pyrazinamide, especially on intermittent therapy].
    Kekkaku; 1972 Dec; 47(12):457-66. PubMed ID: 4652424
    [No Abstract]   [Full Text] [Related]  

  • 7. The Australian rifampicin trial.
    Proust A; Evans C
    Med J Aust; 1972 Oct; 2(16):861-7. PubMed ID: 4647286
    [No Abstract]   [Full Text] [Related]  

  • 8. Intermittent rifampicin treatment of tuberculosis.
    Riska N; Mattson K
    Scand J Respir Dis Suppl; 1973; 84():140-4. PubMed ID: 4522069
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacokinetics of rifampicin].
    Kohno H
    Nihon Kyobu Shikkan Gakkai Zasshi; 1987 Jan; 25(1):32-7. PubMed ID: 3599578
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pulmonary mycobacteriosis due to Mycobacterium battey with favorable development under medical treatment].
    Constans P; Parrot R; Aubriot G; Morin Y; Bariéty M
    Rev Tuberc Pneumol (Paris); 1969 Nov; 33(7):957-66. PubMed ID: 5402998
    [No Abstract]   [Full Text] [Related]  

  • 11. [The pharmacokinetics of rifampicin in the intermittent treatment of patients with pulmonary tuberculosis. 1. Excretion of rifampicin in the urine].
    Winsel K; Eule H; Werner E; Iwainsky H
    Pharmazie; 1985 Apr; 40(4):253-6. PubMed ID: 4011658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effectiveness of oral rifampicin against mycobacteriosis in tropical fish].
    Boos S; Schmidt H; Ritter G; Manz D
    Berl Munch Tierarztl Wochenschr; 1995 Jul; 108(7):253-5. PubMed ID: 8593147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The relation between bacilli negative conversion rate and the number of combined sensitive antituberculous drugs in intermittent administration of rifampicin for severe pulmonary tuberculosis].
    Tamura M; Yamazaki A; Tamura T; Takano S; Yamazaki M
    Kekkaku; 1973 Jul; 48(7):297-302. PubMed ID: 4200058
    [No Abstract]   [Full Text] [Related]  

  • 14. [Investigation on failures in the treatment of pulmonary tuberculosis with rifampicin. Tuberculosis Research Committee. RYOKEN].
    Kekkaku; 1984 Feb; 59(2):91-104. PubMed ID: 6431172
    [No Abstract]   [Full Text] [Related]  

  • 15. Absorption of rifampicin in gastrectomized patients. Effect of meals.
    Hagelund CH; Wåhlén P; Eidsaunet W
    Scand J Respir Dis; 1977 Oct; 58(5):241-6. PubMed ID: 601547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Controlled comparison of daily and intermittent treatment regimens with rifampicin].
    Yamamoto K
    Bull Int Union Tuberc; 1974; 49(1):442-6. PubMed ID: 4619565
    [No Abstract]   [Full Text] [Related]  

  • 17. [A controlled comparison of daily and intermittent administration of rifampicin in retreatment of pulmonary tuberculosis].
    Yamamoto K; Aizawa H; Sasaoka M; Kawamori Y; Kakuno J
    Kekkaku; 1972 Dec; 47(12):467-73. PubMed ID: 4652425
    [No Abstract]   [Full Text] [Related]  

  • 18. Short-course chemotherapy for mycobacteriosis kansasii?
    Schraufnagel DE; Leech JA; Schraufnagel MN; Pollak B
    Can Med Assoc J; 1984 Jan; 130(1):34-8. PubMed ID: 6418368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation on the serum and lung tissue level of rifampicin in man.
    Kiss IJ; Faragó E; Juház I; Bacsa S; Fábián E
    Int J Clin Pharmacol Biopharm; 1976 Jan; 13(1):42-7. PubMed ID: 1248917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rifampicin and ethanbutol in daily and intermittent treatment of chronic advanced cavernous pulmonary tuberculosis resistant to many drugs. Preliminary communication. Early results].
    Zierski M; Bek E; Kucharska A; Graczyk J; Bukalska Z
    Gruzlica; 1973 Nov; 41(11):1129-37. PubMed ID: 4765793
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.